All Videos

VisualDX uses diverse imagery to help increase knowledge of disease manifestations in a range of skin types.

In this fourth part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, talks about what to look forward to in treatment and clinical trials of merkel cell carcinoma (MCC).

In this third part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, highlights the in practice experiences in using circulating tumor DNA for merkel cell carcinoma (MCC).

Dr Andrew Blauvelt reviews key highlights and clinical implications from the LIBERTY AD OLE study assessing the effect of long-term dupilumab treatment on efficacy improvements in adults with moderate to severe atopic dermatitis.

Andrew Blauvelt, MD, MBA, reviews recent advances in the therapeutic landscape for moderate to severe atopic dermatitis.

Christopher Bunick, MD, PhD, offered pointers on how to address the physical and mental aspects of this complex disease in this exclusive interview in conjunction with the American Academy of Dermatology 2022 Annual Meeting.

In this first part of a 4 part video series, Lisa Zaba, MD, PhD, FAAD, explains the science behind her presentation on "The Utility of Circulating Tumor DNA for Detecting Clinically Evident and Occult Merkel Cell Carcinoma." This was presented at the 2022 American Academy of Dermatology Annual Meeting.

In this week’s Pointers with Dr Portela, the 208SkinDoc answers the question, “Should I be taking a collagen supplement?” He breaks down the evidence as the answer is not as simple as it may seem.

In this video interview, Peter A. Lio, MD, FAAD , discusses his presentation about pain-free dermatology at the 2022 American Academy of Dermatology annual meeting. We talk strategies, benefits, and more.

In this video interview, Adam J. Friedman, MD, FAAD, gives the highlights from his presentation at the 2022 American Academy of Dermatology annual meeting about dietary triggers in acne, providing evidence, and discussing how the idea came to be.

In this video interview, we sit down with both Jennifer Lin Hsiao, MD, FAAD, and Scott Worswick, MD, FAAD, to talk in detail about their presentation, "Hidradenitis Suppurativa and Pityriasis Rubra Pilaris: Updates on Treatments for Two Conditions that are Difficult to Manage."

In this video interview, Christopher Bunick, MD, PhD dives into the topic of congenital ichthyosis describing his talk on the skin condition at the American Academy of Dermatology 2022 Annual Meeting.

Christopher Bunick, MD, PhD, talked about his presentation at the 2022 American Academy of Dermatology Annual Meeting on acne, which included a review of updated information on acne and practice pearls.

In this video interview, we sit down with Natasha Atanaskova Mesinkovska, MD, PhD, FAAD, to discuss her 2022 AAD annual meeting presentation on alopecia areata. We dive into pipeline possibilities, what current treatments are missing, and more.

In this week’s Pointers with Dr Portela, the 208SkinDoc discusses how treatments are often too expensive for patients, which causes them to be labeled as “non-compliant.” He discusses ways to improve adherence for both patients and doctors

An expert dermatologist evaluates the role of dupilumab in decreasing the clinical burden of severe atopic dermatitis on patients and their caregivers and shares insight on the future outlook of dupilumab in disease management.

Benjamin Lockshin, MD, FAAD, reviews key findings from a phase 2 trial evaluating the safety and efficacy of single-dose dupilumab in children with severe atopic dermatitis.

Benjamin Lockshin, MD, FAAD, comments on the significance of recent expansions of therapeutics options for patients with atopic dermatitis and unmet needs in the field.

Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.

Experts share insight on the challenges inherent in treating patients with atopic dermatitis despite recent advances in therapy.

In this video the OJM group talks about volatile markets and how to navigate investing in uncertain times.

Concluding their focused discussion on JAK inhibitors in atopic dermatitis, panelists share advice on the optimal selection based on route of administration and use of these agents.

In this week’s Pointers with Dr Portela, the 208SkinDoc interviews Jen Hamilton, a TikTok creator who recently made the decision to go the dermatologist to talk about tackling her acne.

A brief review of 2 oral JAK inhibitors recently approved for patients with atopic dermatitis.

Dermatology Times® interviews editorial board member Richard Gallo, MD, PhD, who dives into what is currently lacking is rosacea patient care, how the new mechanisms of action of these potential treatments will better address current struggles, and more.

Jashin Wu, MD, FAAD, the founder and course director of the 3rd Annual San Diego Dermatology Symposium, offers highlights of the gamechanging topics on the agenda for this in-person conference set for March 11-13, 2022, in San Diego, California. Watch to see more information about the presentations.

In this week’s Pointers with Dr Portela, the 208SkinDoc has a discussion with Marvin Rapaport MD, about the potential adverse events that may occur when patients overuse topical steroids. Watch the interview, meant for educational purposes only, to see what they had to say.

A panel of experts review the use of topical ruxolitinib in atopic dermatitis, shedding light on safety and efficacy considerations.